ESR1 and breast carcinoma: In breast cancer, we (Jansen et al, 2013; Severson et al, 2018) and others (Ross-Innes et al, 2012) identified distinct subsets of ERα chromatin binding profiles with prognostic potential, enabling the stratification of patients on outcome.